| Serial Number | 98720113 |
| Word Mark | KNOMATIC |
| Filing Date | Tuesday, August 27, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, July 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | chemical and biochemical preparations and substances for medical purposes for treatment and diagnosis of cancer, autoimmune disease, and other diseases that involve the functionality of highly dynamic proteins; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders |
| Goods and Services | drug discovery services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; technical consulting in the field of pharmaceutical studies; technical research in the field of pharmaceutical studies; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; providing medical research information in the field of pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of bioinformatics; biological and bio-technology analysis services; DNA sequencing technology research; research in the field of DNA mutation; DNA analysis services for scientific research purposes; providing genetic science information; scientific research consulting in the field of pharmaceuticals and drug discovery; medical and scientific research in the field of proteomics; scientific research for medical purposes in the field of proteomics; drug discovery services that utilize structural analysis, hit finding techniques and computational analysis and targets diseases related to highly dynamic proteins; drug design; analysis of structure activity relationships; drug discovery; pharmaceutical research and development; medical research and development; DNA encoded library (DEL) screening; genetic sequencing services; using artificial intelligence (AI) for drug discovery, pharmaceutical research and development, and medical research and development; using machine learning for drug discovery, pharmaceutical research and development, and medical research and development; drug discovery services targeting diseases related to highly dynamic proteins by utilizing structural analysis, hit finding techniques and computational analysis; drug discovery services for use in developing and prioritizing lead compounds for drug development; drug discovery services in the fields of biochemistry, biophysics, structural biology and chemistry; drug discovery services in the nature of a knowledge based drug discovery platform; drug discovery services in the nature of data analysis software for use in drug discovery; drug discovery services in the nature of drug discovery software utilizing hit finding techniques |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 27, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 27, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, August 19, 2024 |
| First Use In Commerce Date | Monday, August 19, 2024 |
| Party Name | Moma Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
| Event Date | Event Description |
| Tuesday, August 27, 2024 | NEW APPLICATION ENTERED |
| Friday, January 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 4, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, March 11, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 11, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 10, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 10, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 10, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 14, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, July 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 14, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, October 3, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, October 3, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |